These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 38523641)

  • 1. Research progress on the PEGylation of therapeutic proteins and peptides (TPPs).
    Li C; Li T; Tian X; An W; Wang Z; Han B; Tao H; Wang J; Wang X
    Front Pharmacol; 2024; 15():1353626. PubMed ID: 38523641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment-induced and Pre-existing Anti-peg Antibodies: Prevalence, Clinical Implications, and Future Perspectives.
    Gaballa SA; Shimizu T; Ando H; Takata H; Emam SE; Ramadan E; Naguib YW; Mady FM; Khaled KA; Ishida T
    J Pharm Sci; 2024 Mar; 113(3):555-578. PubMed ID: 37931786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of PEGylation on biological therapies.
    Veronese FM; Mero A
    BioDrugs; 2008; 22(5):315-29. PubMed ID: 18778113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEGylated therapeutics in the clinic.
    Gao Y; Joshi M; Zhao Z; Mitragotri S
    Bioeng Transl Med; 2024 Jan; 9(1):e10600. PubMed ID: 38193121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein PEGylation for cancer therapy: bench to bedside.
    Gupta V; Bhavanasi S; Quadir M; Singh K; Ghosh G; Vasamreddy K; Ghosh A; Siahaan TJ; Banerjee S; Banerjee SK
    J Cell Commun Signal; 2019 Sep; 13(3):319-330. PubMed ID: 30499020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Induction of Anti-PEG Immune Responses by PEGylation of Proteins].
    Shimizu T; Ishima Y; Ishida T
    Yakugaku Zasshi; 2020; 140(2):163-169. PubMed ID: 32009039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical modification of protein A chromatography ligands with polyethylene glycol. I: Effects on IgG adsorption equilibrium, kinetics, and transport.
    Weinberg J; Zhang S; Crews G; Carta G; Przybycien T
    J Chromatogr A; 2018 Apr; 1546():77-88. PubMed ID: 29551236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation.
    Zhang P; Sun F; Liu S; Jiang S
    J Control Release; 2016 Dec; 244(Pt B):184-193. PubMed ID: 27369864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylation of cytokines and other therapeutic proteins and peptides: the importance of biological optimisation of coupling techniques.
    Francis GE; Fisher D; Delgado C; Malik F; Gardiner A; Neale D
    Int J Hematol; 1998 Jul; 68(1):1-18. PubMed ID: 9713164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-Specific PEGylation of Therapeutic Proteins.
    Dozier JK; Distefano MD
    Int J Mol Sci; 2015 Oct; 16(10):25831-64. PubMed ID: 26516849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies.
    Chen BM; Cheng TL; Roffler SR
    ACS Nano; 2021 Sep; 15(9):14022-14048. PubMed ID: 34469112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against polyethylene glycol in human blood: A literature review.
    Hong L; Wang Z; Wei X; Shi J; Li C
    J Pharmacol Toxicol Methods; 2020; 102():106678. PubMed ID: 31981619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics.
    Verhoef JJ; Carpenter JF; Anchordoquy TJ; Schellekens H
    Drug Discov Today; 2014 Dec; 19(12):1945-52. PubMed ID: 25205349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antifouling properties of marine antimicrobial peptides by PEGylation.
    Lou T; Bai X; He X; Liu W; Yang Z; Yang Y; Yuan C
    Front Bioeng Biotechnol; 2023; 11():1124389. PubMed ID: 36777243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein carboxyl amidation increases the potential extent of protein polyethylene glycol conjugation.
    Li S; Yang Z; Sun X; Tan Y; Yagi S; Hoffman RM
    Anal Biochem; 2004 Jul; 330(2):264-71. PubMed ID: 15203332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Update on Pharmaceutical Strategies for Oral Delivery of Therapeutic Peptides and Proteins in Adults and Pediatrics.
    Dan N; Samanta K; Almoazen H
    Children (Basel); 2020 Dec; 7(12):. PubMed ID: 33352795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEG - a versatile conjugating ligand for drugs and drug delivery systems.
    Kolate A; Baradia D; Patil S; Vhora I; Kore G; Misra A
    J Control Release; 2014 Oct; 192():67-81. PubMed ID: 24997275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery.
    Milla P; Dosio F; Cattel L
    Curr Drug Metab; 2012 Jan; 13(1):105-19. PubMed ID: 21892917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(l-glutamic acid)-g-poly(ethylene glycol) external layer in polyelectrolyte multilayer films: Characterization and resistance to serum protein adsorption.
    Szczepanowicz K; Kruk T; Świątek W; Bouzga AM; Simon CR; Warszyński P
    Colloids Surf B Biointerfaces; 2018 Jun; 166():295-302. PubMed ID: 29604572
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.